Cabaletta Bio (CABA) Current Leases (2022 - 2025)
Cabaletta Bio's quarterly Current Leases came in at $3.5 million in Q4 2025, down 42.21% year-on-year from $6.0 million in Q4 2024, and down 80.33% quarter-over-quarter from $17.6 million in Q3 2025.
Cabaletta Bio has reported Current Leases for 4 years, with the latest figure at $3.5 million in Q4 2025.
- For the quarter ending Q4 2025, Current Leases fell 42.21% year-over-year to $3.5 million; the trailing twelve-month figure through Dec 2025 stood at $3.5 million (down 42.21% YoY), and the FY2025 full-year result was $3.5 million, down 42.21% from the prior year.
- Current Leases for Q4 2025 stood at $3.5 million, down from $17.6 million in the prior quarter.
- The five-year high for Current Leases was $17.6 million in Q3 2025, with the low at $2.2 million in Q4 2022.
- Average Current Leases over 4 years is $5.6 million, with a median of $4.0 million recorded in 2025.
- Year-over-year, Current Leases jumped 239.48% in 2024 and plunged 46.16% in 2025.
- Tracing CABA's Current Leases over 4 years: stood at $2.2 million in 2022, then climbed by 15.74% to $2.5 million in 2023, then soared by 137.47% to $6.0 million in 2024, then tumbled by 42.21% to $3.5 million in 2025.
- The last three Current Leases figures came in at $3.5 million (Q4 2025), $17.6 million (Q3 2025), and $4.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Cabaletta Bio | 194.84 Mn | 61.24 Mn | - | 3.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.46 Mn |
| Sep 30, 2025 | 17.60 Mn |
| Jun 30, 2025 | 3.99 Mn |
| Mar 31, 2025 | 3.99 Mn |
| Dec 31, 2024 | 5.99 Mn |
| Sep 30, 2024 | 7.94 Mn |
| Jun 30, 2024 | 7.40 Mn |
| Mar 31, 2024 | 7.40 Mn |
| Sep 30, 2023 | 2.52 Mn |
| Jun 30, 2023 | 2.18 Mn |
| Mar 31, 2023 | 2.18 Mn |
| Dec 31, 2022 | 2.18 Mn |